Cargando…
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
BACKGROUND: Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory effects. Our aim was to identify whether metformin reduced COVID-19-related mortality and whether sex-specific interacti...
Autores principales: | Bramante, Carolyn T, Ingraham, Nicholas E, Murray, Thomas A, Marmor, Schelomo, Hovertsen, Shane, Gronski, Jessica, McNeil, Chace, Feng, Ruoying, Guzman, Gabriel, Abdelwahab, Nermine, King, Samantha, Tamariz, Leonardo, Meehan, Thomas, Pendleton, Kathryn M, Benson, Bradley, Vojta, Deneen, Tignanelli, Christopher J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832552/ https://www.ncbi.nlm.nih.gov/pubmed/33521772 http://dx.doi.org/10.1016/S2666-7568(20)30033-7 |
Ejemplares similares
-
Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
por: Bramante, Carolyn T., et al.
Publicado: (2020) -
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
por: Ibrahim, Sherehan, et al.
Publicado: (2021) -
Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity
por: Bramante, Carolyn T., et al.
Publicado: (2021) -
Treatment Receipt and Outcomes of Self-Reported Voice Problems in the US Population Aged ≥65 Years
por: Marmor, Schelomo, et al.
Publicado: (2018) -
Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease
por: Tignanelli, Christopher J., et al.
Publicado: (2021)